Paris, France ; Cambridge, MA (USA); October 27, 2022 – NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the “Company”) is a French biotechnology company in late-stage clinical development, pioneering physics-based approaches to expand treatment options for patients with cancer, today announces that Laurent Levy, co-founder and chairman of the board, and Bart Van Rhijn, chief financial officer, will participate in a fireside chat on Tuesday, November 15, 2022 at 5 p.m. GMT/ 12 p.m. ET during the Jefferies Healthcare Conference in London.
The presentation will be streamed live on the Events page of the Investors section of the Company’s website. A replay will be available for at least 30 days after the event.